120 related articles for article (PubMed ID: 33312320)
1. Pulmonary and intracranial miliary tuberculosis secondary to Behçet's anti-TNF alfa treatment.
Sekkat A; Bouchal S; Charifi Y; Hajjam KE; Alaoui YL; Belahsen MF; Maaroufi M; Alami B
Radiol Case Rep; 2021 Feb; 16(2):338-342. PubMed ID: 33312320
[TBL] [Abstract][Full Text] [Related]
2. Intestinal perforation due to miliary tuberculosis in a patient with Behcet's disease.
Kapan M; Karabicak I; Aydogan F; Kusaslan R; Kisacik B
Mt Sinai J Med; 2006 Sep; 73(5):825-7. PubMed ID: 17008948
[TBL] [Abstract][Full Text] [Related]
3. Resuming anti-TNF therapy after development of miliary tuberculosis in Behcet's disease-related uveitis: a case report.
Toriu C; Tsubota K; Usui Y; Goto H
J Ophthalmic Inflamm Infect; 2023 Nov; 13(1):52. PubMed ID: 38017191
[TBL] [Abstract][Full Text] [Related]
4. Frosted branch angiitis and cerebral venous sinus thrombosis as an initial onset of neuro-Behçet's disease: a case report and review of the literature.
Ferreira BFA; Rodriguez EEC; Prado LLD; Gonçalves CR; Hirata CE; Yamamoto JH
J Med Case Rep; 2017 Apr; 11(1):104. PubMed ID: 28410605
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
Hu YC; Yang YH; Lin YT; Wang LC; Yu HH; Lee JH; Chiang BL
BMC Pediatr; 2019 Jul; 19(1):232. PubMed ID: 31296171
[TBL] [Abstract][Full Text] [Related]
6. Behçet's disease-like syndrome secondary to microbial infection: a case report and review of the literature.
Zhang L; Xu Y; Peng Y; Yan B; Liu Y
Int J Clin Exp Pathol; 2015; 8(10):13619-24. PubMed ID: 26722585
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
Zlatanović G; Jovanović S; Veselinović D; Zivković M
Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary artery aneurysms in Behçet's disease treated with anti-TNFα: A case series and review of the literature.
Chan E; Sangle SR; Coghlan JG; D'Cruz DD
Autoimmun Rev; 2016 Apr; 15(4):375-8. PubMed ID: 26777307
[TBL] [Abstract][Full Text] [Related]
9. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
[TBL] [Abstract][Full Text] [Related]
10. Miliary tuberculosis developing during adalimumab treatment for Behçet's disease with uveitis.
Kim MJ; Jones N; Steeples LR
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567192
[TBL] [Abstract][Full Text] [Related]
11. [Acute psychosis and Behçet's disease: a case report].
Nkam I; Cottereau MJ
Encephale; 2006; 32(3 Pt 1):385-8. PubMed ID: 16840933
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behçet's disease.
Duymaz-Tozkir J; Gül A; Uyar FA; Ozbek U; Saruhan-Direskeneli G
Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S15-8. PubMed ID: 14727453
[TBL] [Abstract][Full Text] [Related]
13. Budd-Chiari syndrome caused by Behçet's disease: treatment by side-to-side portacaval shunt.
Orloff LA; Orloff MJ
J Am Coll Surg; 1999 Apr; 188(4):396-407. PubMed ID: 10195724
[TBL] [Abstract][Full Text] [Related]
14. Resolution of Behçet's syndrome associated pulmonary arterial aneurysms with infliximab.
Schreiber BE; Noor N; Juli CF; Haskard DO
Semin Arthritis Rheum; 2011 Dec; 41(3):482-7. PubMed ID: 21546064
[TBL] [Abstract][Full Text] [Related]
15. Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.
Park J; Cheon JH
Gut Liver; 2018 Nov; 12(6):623-632. PubMed ID: 29788675
[TBL] [Abstract][Full Text] [Related]
16. Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.
Sugimura N; Mizoshita T; Sugiyama T; Togawa S; Miyaki T; Suzuki T; Tanida S; Kataoka H; Sasaki M
Dig Liver Dis; 2019 Jul; 51(7):967-971. PubMed ID: 30872086
[TBL] [Abstract][Full Text] [Related]
17. [Ocular manifestations in Behçet's disease].
Desbois AC; Terrada C; Cacoub P; Bodaghi B; Saadoun D
Rev Med Interne; 2018 Sep; 39(9):738-745. PubMed ID: 29625716
[TBL] [Abstract][Full Text] [Related]
18. Manifestations of Neuro-Behcet's disease. Report of two cases and review of the literature.
Ho CL; Deruytter MJ
Clin Neurol Neurosurg; 2005 Jun; 107(4):310-4. PubMed ID: 15885390
[TBL] [Abstract][Full Text] [Related]
19. [Not Available].
Brenière C; Blanc C; Devilliers H; Samson M; Delpont B; Bielefeld P; Besancenot JF; Giroud M; Béjot Y
Rev Neurol (Paris); 2018 May; 174(5):337-341. PubMed ID: 29704959
[TBL] [Abstract][Full Text] [Related]
20. Interferon alfa-2a in the treatment of Behçet's disease.
Azizlerli G; Sarica R; Köse A; Ovül C; Kavala M; Kayabali M; Erkan F; Kural Z
Dermatology; 1996; 192(3):239-41. PubMed ID: 8726638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
